| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
N-acetylneuraminate synthase | 0.545 | 0.692 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
protein inhibitor of activated STAT 4 | 0.678 | 0.538 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
doublecortin domain containing 2 | 0.546 | 0.769 | 5.7E-10 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
phosphodiesterase 4A | 0.523 | 0.846 | 0.98 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
proteasome maturation protein | 0.674 | 0.346 | 0.91 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
zinc finger MYND-type containing 10 | 0.553 | 0.731 | 2.3E-07 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
cell division cycle 40 | 1.000 | 0.077 | 0.98 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
toll like receptor 7 | 0.464 | 0.885 | 0.98 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
cyclin dependent kinase like 3 | 0.890 | 0.231 | 2.3E-12 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
glycoprotein VI platelet | 0.597 | 0.615 | 1.6E-11 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
platelet derived growth factor receptor beta | 0.416 | 0.846 | 0.90 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
tripartite motif containing 33 | 0.626 | 0.577 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
toll like receptor 9 | 0.411 | 0.885 | 9.8E-06 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
sperm autoantigenic protein 17 | 0.647 | 0.577 | 6.6E-03 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
phospholipase C beta 4 | 0.610 | 0.731 | 3.0E-06 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
phospholipase A2 group IVA | 0.496 | 0.846 | 6.0E-05 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
phosphatidylinositol-5-phosphate 4-kinase type 2 alpha | 0.647 | 0.423 | 0.14 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
phosphoglycerate kinase 1 | 0.542 | 0.769 | 0.77 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1992 | 1992 | ||||||||
|
regulator of telomere elongation helicase 1 | 0.459 | 0.808 | 8.9E-10 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
acyl-CoA synthetase long chain family member 5 | 0.641 | 0.500 | 2.9E-09 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
NBAS subunit of NRZ tethering complex | 0.566 | 0.692 | 5.0E-43 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2009 | 2009 | ||||||||
|
interleukin 1 receptor associated kinase 4 | 0.578 | 0.769 | 7.8E-09 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
proliferating cell nuclear antigen | 0.382 | 0.846 | 0.98 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
NME/NM23 nucleoside diphosphate kinase 4 | 0.760 | 0.308 | 1.0E-03 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
NME/NM23 nucleoside diphosphate kinase 1 | 0.443 | 0.808 | 3.2E-03 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 |